Literature DB >> 21057216

AMPK signaling: a targetable tumor suppressor pathway?

Abraham Schneider1, Ronald B Gartenhaus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21057216      PMCID： PMC5611871          DOI： 10.4161/cbt.10.11.13921

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN： 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  33 in total

Review 1.  The multiple roles of PTEN in tumor suppression.

Authors:  A Di Cristofano; P P Pandolfi
Journal:  Cell       Date:  2000-02-18       Impact factor: 41.582

Review 2.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

3.  Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells.

Authors:  Mahvash Zakikhani; Ryan Dowling; I George Fantus; Nahum Sonenberg; Michael Pollak
Journal:  Cancer Res       Date:  2006-10-23       Impact factor: 12.701

4.  Rheb binds and regulates the mTOR kinase.

Authors:  Xiaomeng Long; Yenshou Lin; Sara Ortiz-Vega; Kazuyoshi Yonezawa; Joseph Avruch
Journal:  Curr Biol       Date:  2005-04-26       Impact factor: 10.834

5.  Akt regulates growth by directly phosphorylating Tsc2.

Authors:  Christopher J Potter; Laura G Pedraza; Tian Xu
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

6.  Statin-dependent suppression of the Akt/mammalian target of rapamycin signaling cascade and programmed cell death 4 up-regulation in renal cell carcinoma.

Authors:  Jennifer Woodard; Antonella Sassano; Nissim Hay; Leonidas C Platanias
Journal:  Clin Cancer Res       Date:  2008-07-15       Impact factor: 12.531

7.  The LKB1 tumor suppressor negatively regulates mTOR signaling.

Authors:  Reuben J Shaw; Nabeel Bardeesy; Brendan D Manning; Lyle Lopez; Monica Kosmatka; Ronald A DePinho; Lewis C Cantley
Journal:  Cancer Cell       Date:  2004-07       Impact factor: 31.743

Review 8.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.

Authors:  Ralph J DeBerardinis; Julian J Lum; Georgia Hatzivassiliou; Craig B Thompson
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

9.  AMPK phosphorylation of raptor mediates a metabolic checkpoint.

Authors:  Dana M Gwinn; David B Shackelford; Daniel F Egan; Maria M Mihaylova; Annabelle Mery; Debbie S Vasquez; Benjamin E Turk; Reuben J Shaw
Journal:  Mol Cell       Date:  2008-04-25       Impact factor: 17.970

Review 10.  Targeting the translational machinery as a novel treatment strategy for hematologic malignancies.

Authors:  Patrick R Hagner; Abraham Schneider; Ronald B Gartenhaus
Journal:  Blood       Date:  2010-01-14       Impact factor: 22.113
View more
  2 in total

1.  Functional organic cation transporters mediate osteogenic response to metformin in human umbilical cord mesenchymal stromal cells.

Authors:  Faisal E Al Jofi; Tao Ma; Dong Guo; Monica P Schneider; Yan Shu; Hockin H K Xu; Abraham Schneider
Journal:  Cytotherapy       Date:  2018-03-16       Impact factor: 5.414

2.  8-Chloroadenosine Sensitivity in Renal Cell Carcinoma Is Associated with AMPK Activation and mTOR Pathway Inhibition.

Authors:  Alper Y Kearney; You-Hong Fan; Uma Giri; Babita Saigal; Varsha Gandhi; John V Heymach; Amado J Zurita
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.